mifepristone has been researched along with brl 37344 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baude, B; Emorine, LJ; Fève, B; Krief, S; Pairault, J; Strosberg, AD | 1 |
Collins, S; Gettys, TW; Taylor, IL; Watson, PM | 1 |
2 other study(ies) available for mifepristone and brl 37344
Article | Year |
---|---|
Inhibition by dexamethasone of beta 3-adrenergic receptor responsiveness in 3T3-F442A adipocytes. Evidence for a transcriptional mechanism.
Topics: 3T3 Cells; Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Animals; Base Sequence; Cell Membrane; Dexamethasone; Dose-Response Relationship, Drug; Ethanolamines; Isoproterenol; Kinetics; Mice; Mifepristone; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Polymerase Chain Reaction; Progesterone; Propanolamines; Receptors, Adrenergic, beta; RNA; Transcription, Genetic | 1992 |
RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient beta-adrenergic signalling in adipocytes from mature C57BL/6J-ob/ob mice.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Animals; Blood Glucose; Blotting, Northern; Blotting, Western; Colforsin; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Activation; Ethanolamines; Glucose Transporter Type 4; GTP-Binding Protein alpha Subunits, Gs; Hormone Antagonists; Insulin; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mifepristone; Monosaccharide Transport Proteins; Muscle Proteins; Phenotype; Receptors, Adrenergic, beta; Receptors, Glucocorticoid; Signal Transduction | 1997 |